Most Read Articles
2 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, Yesterday
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Which toric IOL formula best predicts postoperative astigmatic outcome?

21 Nov 2020

A new study has shown that using the Kane toric formula significantly enhances the prediction of postoperative astigmatic outcome in comparison to other modern toric intraocular lens (IOL) formulas analysed.

In this retrospective consecutive case series, the authors used a large database of toric IOL refractive outcomes to compare the accuracy of the Abulafia-Koch, the Barrett, the EVO 2.0, the new Holladay 2 with total surgical-induced astigmatism, the Kane, and the Næser-Savini power formulas among 823 eyes of 823 patients who had a toric IOL inserted during surgery.

One eligible eye from patients having uncomplicated cataract surgery with insertion of an Alcon SN6AT(2-9) IOL from one surgeon was eligible for inclusion. Either the IOLMaster 500 or 700 was used to measure both pre- and postoperative biometry. The predicted postoperative refractive astigmatism was calculated for each formula using vector calculation. The authors then compared this with the actual postoperative refractive astigmatism to give the prediction error.

The greatest proportion of eyes with a prediction error within ±0.50 dioptre was observed with the Kane formula (65.6 percent), followed by the Barrett formula (59.9 percent), Abulafia-Koch formula (59.5 percent), EVO 2.0 formula (58.9 percent), Næser-Savini formula (56.7 percent), and Holladay 2 formula (53.9 percent).

The Kane formula also displayed a statistically significantly lower mean absolute prediction error (p<0.001) and a markedly lower variance of the prediction error (p<0.01) relative to all other formulas. There was no statistically significant difference seen among the mean absolute prediction errors for the Abulafia-Koch, Barrett, and EVO 2.0 toric formulas.

Editor's Recommendations
Most Read Articles
2 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, Yesterday
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.